Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Ischemic Heart Disease

Free Subscription Articles published in Atherosclerosis Retrieve available abstracts of 180 articles: HTML format

Single Articles

April 2024
1. GAGNON E, Arsenault BJ
   Drug target Mendelian randomization supports apolipoprotein C3-lowering for lipoprotein-lipid levels reductions and cardiovascular diseases prevention.
   Atherosclerosis. 2024;391:117501.
   PubMed     Abstract available
   
   
   
2. HAN Y, Ren L, Fei X, Wang J, et al
   Effect of combining evolocumab with statin on carotid intraplaque neovascularization in patients with premature coronary artery disease (EPOCH).
   Atherosclerosis. 2024;391:117471.
   PubMed     Abstract available
   
   
   
3. RINALDI R, Colucci M, Torre I, Ausiello D, et al
   Predicting the response to acetylcholine in ischemia or infarction with non-obstructive coronary arteries: The ABCD score.
   Atherosclerosis. 2024;391:117503.
   PubMed     Abstract available
   
   
   March 2024
4. REXHAJ E, Bar S, Soria R, Ueki Y, et al
   Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy.
   Atherosclerosis. 2024;392:117504.
   PubMed     Abstract available
   
   
   
5. HAKAMAA E, Goebeler S, Martiskainen M, Louhelainen AM, et al
   Sex differences in coronary atherosclerosis during the pre- and postmenopausal period: The Tampere Sudden Death Study.
   Atherosclerosis. 2024;390:117459.
   PubMed     Abstract available
   
   
   
6. GRINBERG T, Eisen A, Talmor-Barkan Y, Kornowski R, et al
   Novel plasma biomarkers of coronary artery calcium incidence or progression: Insights from the prospective multi-ethnic Dallas Heart Study cohort.
   Atherosclerosis. 2024;390:117469.
   PubMed     Abstract available
   
   
   
7. SCHLEGEL A
   Diagnostic challenge of an APOB variant of uncertain significance resolved by transheterozygosity with a pathological LDLR variant and clinical response to therapy.
   Atherosclerosis. 2024;390:117460.
   PubMed    
   
   
   
8. CHEDID G, Malik A, Daher R, Welty FK, et al
   Reply to: "Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease"".
   Atherosclerosis. 2024;390:117452.
   PubMed    
   
   
   
9. KHAN SU, Al-Mallah MH
   Air pollution and acute coronary syndrome: The air we breathe.
   Atherosclerosis. 2024;390:117453.
   PubMed    
   
   
   
10. GU SZ, Ahmed ME, Huang Y, Hakim D, et al
    Comprehensive biomechanical and anatomical atherosclerotic plaque metrics predict major adverse cardiovascular events: A new tool for clinical decision making.
    Atherosclerosis. 2024;390:117449.
    PubMed     Abstract available
    
    
    
11. CENKO E, Manfrini O, Bugiardini R
    Net adverse clinical events with P2Y(12) inhibitor therapy in older patients after percutaneous coronary interventions.
    Atherosclerosis. 2024;390:117434.
    PubMed    
    
    
    
12. ASMARIAN N, Raeisi Shahraki H
    Comments on "Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease".
    Atherosclerosis. 2024;390:117426.
    PubMed    
    
    
    
13. RINALDI R, Russo M, Bonanni A, Camilli M, et al
    Short-term air pollution exposure and mechanisms of plaque instability in acute coronary syndromes: An optical coherence tomography study.
    Atherosclerosis. 2024;390:117393.
    PubMed     Abstract available
    
    
    February 2024
14. BASU P, Das AA, Siddiqui KN, Mondal PC, et al
    Novel role of peptidoglycan recognition protein 2 in activating NOD2-NFkappaB inflammatory axis in coronary artery disease.
    Atherosclerosis. 2024;389:117436.
    PubMed     Abstract available
    
    
    January 2024
15. XU M, Hou Z, Koyratty N, Huang C, et al
    Association between long-term exposure to ambient air pollution and lesion ischemia in patients with atherosclerosis.
    Atherosclerosis. 2024;388:117422.
    PubMed     Abstract available
    
    
    
16. KADIYALA V, Khetpal V, Hulten EA
    Coronary artery calcium screening: He who buys what he does not need steals from himself.
    Atherosclerosis. 2024;388:117411.
    PubMed    
    
    
    
17. QIU Y, Hao W, Guo Y, Guo Q, et al
    The association of lipoprotein (a) with coronary artery calcification: A systematic review and meta-analysis.
    Atherosclerosis. 2024;388:117405.
    PubMed     Abstract available
    
    
    
18. ACQUAH I, Cainzos-Achirica M, Taha MB, Lahan S, et al
    Social disadvantage, coronary artery calcium, and their interplay in the prediction of atherosclerotic cardiovascular disease events.
    Atherosclerosis. 2024;388:117355.
    PubMed     Abstract available
    
    
    December 2023
19. WODAJE T, Mahdi A, Venkateshvaran A, Habel H, et al
    Higher prevalence of coronary microvascular dysfunction in asymptomatic individuals with high levels of lipoprotein(a) with and without heterozygous familial hypercholesterolaemia.
    Atherosclerosis. 2023;389:117439.
    PubMed     Abstract available
    
    
    
20. FISHBEIN I, Inamdar VV, Alferiev IS, Bratinov G, et al
    Hypercholesterolemia exacerbates in-stent restenosis in rabbits: Studies of the mitigating effect of stent surface modification with a CD47-derived peptide.
    Atherosclerosis. 2023;390:117432.
    PubMed     Abstract available
    
    
    
21. ZHANG D, Li P, Qiu M, Liang Z, et al
    Net clinical benefit of clopidogrel versus ticagrelor in elderly patients carrying CYP2C19 loss-of-function variants with acute coronary syndrome after percutaneous coronary intervention.
    Atherosclerosis. 2023 Dec 13:117395. doi: 10.1016/j.atherosclerosis.2023.117395.
    PubMed     Abstract available
    
    
    
22. DONG JY, Iso H, Muraki I, Tanaka M, et al
    Timing of clinic visits after health checks and risk of hospitalization for cardiovascular events and all-cause death among the high-risk population.
    Atherosclerosis. 2023;388:117409.
    PubMed     Abstract available
    
    
    
23. HARIRI E, Asbeutah AA, Malik A, Amangurbanova M, et al
    Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.
    Atherosclerosis. 2023;387:117388.
    PubMed     Abstract available
    
    
    
24. TZIOTZIOU A, Hartman E, Korteland SA, van der Lugt A, et al
    Mechanical wall stress and wall shear stress are associated with atherosclerosis development in non-calcified coronary segments.
    Atherosclerosis. 2023;387:117387.
    PubMed     Abstract available
    
    
    
25. KHEIRKHAH A, Schachtl-Riess JF, Lamina C, Di Maio S, et al
    Meta-GWAS on PCSK9 concentrations reveals associations of novel loci outside the PCSK9 locus in White populations.
    Atherosclerosis. 2023;386:117384.
    PubMed     Abstract available
    
    
    
26. OMORI H, Matsuo H, Fujimoto S, Sobue Y, et al
    Determination of lipid-rich plaques by artificial intelligence-enabled quantitative computed tomography using near-infrared spectroscopy as reference.
    Atherosclerosis. 2023;386:117363.
    PubMed     Abstract available
    
    
    
27. FAHED AC, Natarajan P
    Clinical applications of polygenic risk score for coronary artery disease through the life course.
    Atherosclerosis. 2023;386:117356.
    PubMed     Abstract available
    
    
    November 2023
28. BJORNSON E, Adiels M, Bergstrom G, Gummesson A, et al
    The relationship between genetic liver fat and coronary heart disease is explained by apoB-containing lipoproteins.
    Atherosclerosis. 2023 Nov 29:117397. doi: 10.1016/j.atherosclerosis.2023.117397.
    PubMed     Abstract available
    
    
    
29. LAI Z, Wu G, Yang Y, Chen L, et al
    Interactive effects of physical activity and sarcopenia on incident ischemic heart disease: Results from a nation-wide cohort study.
    Atherosclerosis. 2023;388:117396.
    PubMed     Abstract available
    
    
    
30. MARTIN-CAMPOS JM, Carcel-Marquez J, Llucia-Carol L, Lledos M, et al
    Causal role of lipid metabolome on the risk of ischemic stroke, its etiological subtypes, and long-term outcome: A Mendelian randomization study.
    Atherosclerosis. 2023;386:117382.
    PubMed     Abstract available
    
    
    
31. SAKKERS TR, Mokry M, Civelek M, Erdmann J, et al
    Sex differences in the genetic and molecular mechanisms of coronary artery disease.
    Atherosclerosis. 2023;384:117279.
    PubMed     Abstract available
    
    
    
32. CIVIERI G, Kerkhof PLM, Montisci R, Iliceto S, et al
    Sex differences in diagnostic modalities of coronary artery disease: Evidence from coronary microcirculation.
    Atherosclerosis. 2023;384:117276.
    PubMed     Abstract available
    
    
    
33. CROOIJMANS J, Singh S, Naqshband M, Bruikman CS, et al
    Premature atherosclerosis: An analysis over 39 years in the Netherlands. Implications for young individuals in high-risk families.
    Atherosclerosis. 2023;384:117267.
    PubMed     Abstract available
    
    
    
34. GURGOGLIONE FL, Solinas E, Pfleiderer B, Vezzani A, et al
    Coronary atherosclerotic plaque phenotype and physiopathologic mechanisms: Is there an influence of sex? Insights from intracoronary imaging.
    Atherosclerosis. 2023;384:117273.
    PubMed     Abstract available
    
    
    
35. HOLTZMAN JN, Kaur G, Hansen B, Bushana N, et al
    Sex differences in the management of atherosclerotic cardiovascular disease.
    Atherosclerosis. 2023;384:117268.
    PubMed     Abstract available
    
    
    
36. CHEDID G, Malik A, Daher R, Welty FK, et al
    Higher exercise capacity, but not omega-3 fatty acid consumption, predicts lower coronary artery calcium scores in women and men with coronary artery disease.
    Atherosclerosis. 2023;384:117168.
    PubMed     Abstract available
    
    
    
37. KANG J, Cho Y
    Sex differences in the association between minor nonspecific ST-segment and T-wave abnormalities and coronary artery calcification.
    Atherosclerosis. 2023;384:117154.
    PubMed     Abstract available
    
    
    
38. LU C, Donners MMPC, Karel J, de Boer H, et al
    Sex-specific differences in cytokine signaling pathways in circulating monocytes of cardiovascular disease patients.
    Atherosclerosis. 2023;384:117123.
    PubMed     Abstract available
    
    
    
39. NELLES G, Abdelwahed YS, Alyaqoob A, Seppelt C, et al
    Spotty calcium deposits within acute coronary syndrome (ACS)-causing culprit lesions impact inflammatory vessel-wall interactions and are associated with higher cardiovascular event rates at one year follow-up: Results from the prospective translation
    Atherosclerosis. 2023;385:117284.
    PubMed     Abstract available
    
    
    
40. PONTONE G, Rossi A, Gimelli A, Neglia D, et al
    Should we choose CT angiography first instead of SPECT/PET first for the diagnosis and management of coronary artery disease?
    Atherosclerosis. 2023;385:117315.
    PubMed     Abstract available
    
    
    
41. RASMUSSEN KL, Luo J, Nordestgaard BG, Tybjaerg-Hansen A, et al
    APOE and vascular disease: Sequencing and genotyping in general population cohorts.
    Atherosclerosis. 2023;385:117218.
    PubMed     Abstract available
    
    
    
42. LARSSON J, Auscher S, Shamoun A, Pararajasingam G, et al
    Insulin resistance is associated with high-risk coronary artery plaque composition in asymptomatic men between 65 and 75 years and no diabetes: A DANCAVAS cross-sectional sub-study.
    Atherosclerosis. 2023;385:117328.
    PubMed     Abstract available
    
    
    October 2023
43. LANDMESSER U, Koenig W, Leiter LA, Raal FJ, et al
    Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trials.
    Atherosclerosis. 2023;386:117354.
    PubMed     Abstract available
    
    
    
44. JUNNA N, Ruotsalainen S, Ripatti P, FinnGen, et al
    Novel Finnish-enriched variants causing severe hypercholesterolemia and their clinical impact on coronary artery disease.
    Atherosclerosis. 2023 Oct 12:117327. doi: 10.1016/j.atherosclerosis.2023.117327.
    PubMed     Abstract available
    
    
    
45. PAGE MM, Hardikar W, Alex G, Bates S, et al
    Long-term outcomes of liver transplantation for homozygous familial hypercholesterolaemia in Australia and New Zealand.
    Atherosclerosis. 2023 Oct 10:117305. doi: 10.1016/j.atherosclerosis.2023.117305.
    PubMed     Abstract available
    
    
    
46. WILLIAMS C, Han D, Takagi H, Fordyce CB, et al
    Effects of renin-angiotensin-aldosterone-system inhibitors on coronary atherosclerotic plaques: The PARADIGM registry.
    Atherosclerosis. 2023;383:117301.
    PubMed     Abstract available
    
    
    September 2023
47. HAMAYA R, Goto S, Hwang D, Zhang J, et al
    Machine-learning-based prediction of fractional flow reserve after percutaneous coronary intervention.
    Atherosclerosis. 2023;383:117310.
    PubMed     Abstract available
    
    
    
48. SONG Z, Wan L, Wang W, Li Y, et al
    Daily stair climbing, disease susceptibility, and risk of atherosclerotic cardiovascular disease: A prospective cohort study.
    Atherosclerosis. 2023 Sep 16:117300. doi: 10.1016/j.atherosclerosis.2023.117300.
    PubMed     Abstract available
    
    
    
49. LEE YH, Hsieh MT, Chang CC, Tsai YL, et al
    Improving detection of obstructive coronary artery disease with an artificial intelligence-enabled electrocardiogram algorithm.
    Atherosclerosis. 2023;381:117238.
    PubMed     Abstract available
    
    
    
50. KWIECINSKI J, Oleksiak A, Kruk M, Zysk A, et al
    Computed tomography perfusion and angiography in patients with chronic total occlusion undergoing percutaneous coronary intervention.
    Atherosclerosis. 2023;381:117174.
    PubMed     Abstract available
    
    
    August 2023
51. ZHAO JV, Fan B, Burgess S
    Using genetics to examine the overall and sex-specific associations of branch-chain amino acids and the valine metabolite, 3-hydroxyisobutyrate, with ischemic heart disease and diabetes: A two-sample Mendelian randomization study.
    Atherosclerosis. 2023;381:117246.
    PubMed     Abstract available
    
    
    
52. CASULA M, Gazzotti M, Capra ME, Olmastroni E, et al
    Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study.
    Atherosclerosis. 2023 Aug 12:117231. doi: 10.1016/j.atherosclerosis.2023.117231.
    PubMed     Abstract available
    
    
    
53. KOSKA J, Hu Y, Furtado J, Billheimer D, et al
    Association of apolipoproteins C-I and C-II truncations with coronary heart disease and progression of coronary artery calcium: Multi-Ethnic Study of Atherosclerosis.
    Atherosclerosis. 2023;380:117214.
    PubMed     Abstract available
    
    
    
54. HON A, Hsu JJ, Zambrano A, Xia Y, et al
    Effects of activity levels on aortic calcification in hyperlipidemic mice as measured by microPETmicroCT.
    Atherosclerosis. 2023;380:117198.
    PubMed     Abstract available
    
    
    
55. WANG C, Tian X, Feng X, Demuyakor A, et al
    Pancoronary plaque characteristics and clinical outcomes in acute coronary syndrome patients with cancer history.
    Atherosclerosis. 2023;378:117118.
    PubMed     Abstract available
    
    
    July 2023
56. OJEDA-RODRIGUEZ A, Alcala-Diaz JF, Rangel-Zuniga OA, Arenas-de Larriva AP, et al
    Association between telomere length and intima-media thickness of both common carotid arteries in patients with coronary heart disease: From the CORDIOPREV randomized controlled trial.
    Atherosclerosis. 2023;380:117193.
    PubMed     Abstract available
    
    
    
57. FU Y, Yusufu M, Wang Y, He M, et al
    Association of retinal microvascular density and complexity with incident coronary heart disease.
    Atherosclerosis. 2023;380:117196.
    PubMed     Abstract available
    
    
    
58. ADAY AW, Bagheri M, Vaitinadin NS, Mosley JD, et al
    Polygenic risk score in comparison with C-reactive protein for predicting incident coronary heart disease.
    Atherosclerosis. 2023;379:117194.
    PubMed     Abstract available
    
    
    
59. VINK CEM, Woudstra J, Lee JM, Boerhout CKM, et al
    Sex differences in prevalence and outcomes of the different endotypes of chronic coronary syndrome in symptomatic patients undergoing invasive coronary angiography: Insights from the global ILIAS invasive coronary physiology registry.
    Atherosclerosis. 2023 Jul 8:117167. doi: 10.1016/j.atherosclerosis.2023.
    PubMed     Abstract available
    
    
    
60. LI Z, Lin C, Cai X, Hu S, et al
    Anti-inflammatory therapies were associated with reduced risk of myocardial infarction in patients with established cardiovascular disease or high cardiovascular risks: A systematic review and meta-analysis of randomized controlled trials.
    Atherosclerosis. 2023;379:117181.
    PubMed     Abstract available
    
    
    
61. KRALER S, Wenzl FA, Vykoukal J, Fahrmann JF, et al
    Low-density lipoprotein electronegativity and risk of death after acute coronary syndromes: A case-cohort analysis.
    Atherosclerosis. 2023;376:43-52.
    PubMed     Abstract available
    
    
    
62. DALILA N, Frikke-Schmidt R, Nordestgaard BG, Tybjaerg-Hansen A, et al
    Plasma TSH and cardiovascular disease in the general population: A Mendelian randomization study of 105,224 individuals.
    Atherosclerosis. 2023;376:26-33.
    PubMed     Abstract available
    
    
    
63. NOORDAM R, Brochard TA, Drewes YM, Gussekloo J, et al
    Cardiovascular risk factors and major recurrent coronary events: A genetic liability study in patients with coronary artery disease in the UK Biobank.
    Atherosclerosis. 2023;376:19-25.
    PubMed     Abstract available
    
    
    
64. HAKIM D, Pinilla-Echeverri N, Coskun AU, Pu Z, et al
    The role of endothelial shear stress, shear stress gradient, and plaque topography in plaque erosion.
    Atherosclerosis. 2023;376:11-18.
    PubMed     Abstract available
    
    
    June 2023
65. TONA F, Vadori M, Civieri G, Masiero G, et al
    Association of autoantibodies targeting endothelin type-A receptors with no-reflow in ST-elevation myocardial infarction.
    Atherosclerosis. 2023 Jun 28:117179. doi: 10.1016/j.atherosclerosis.2023.
    PubMed     Abstract available
    
    
    
66. ZHANG K, Liu C, Sha X, Yao S, et al
    Development and validation of a prediction model to predict major adverse cardiovascular events in elderly patients undergoing noncardiac surgery: A retrospective cohort study.
    Atherosclerosis. 2023;376:71-79.
    PubMed     Abstract available
    
    
    
67. LOPEZ RODRIGUEZ M, Arasu UT, Kaikkonen MU
    Exploring the genetic basis of coronary artery disease using functional genomics.
    Atherosclerosis. 2023;374:87-98.
    PubMed     Abstract available
    
    
    May 2023
68. DOI T, Langsted A, Nordestgaard BG
    Dual elevated remnant cholesterol and C-reactive protein in myocardial infarction, atherosclerotic cardiovascular disease, and mortality.
    Atherosclerosis. 2023 May 13:S0021-9150(23)00204.
    PubMed     Abstract available
    
    
    
69. KUEHNEMUND L, Lange SA, Feld J, Padberg JS, et al
    Sex disparities in guideline-recommended therapies and outcomes after ST-elevation myocardial infarction in a contemporary nationwide cohort of patients over an eight-year period.
    Atherosclerosis. 2023;375:30-37.
    PubMed     Abstract available
    
    
    
70. KUMAR A, Stillman AE, Chatzizisis YS
    Coronary plaque phenotyping with cardiac CTA: Separating the signal from the noise.
    Atherosclerosis. 2023;373:66-68.
    PubMed    
    
    
    
71. LEMIEUX I, Despres JP
    Weight gain with age and coronary atherosclerosis: Only the tip of a deadly iceberg.
    Atherosclerosis. 2023;373:55-57.
    PubMed    
    
    
    
72. YANG S, Lesina K, Doh JH, Jegere S, et al
    Long-term prognostic implications of hemodynamic and plaque assessment using coronary CT angiography.
    Atherosclerosis. 2023;373:58-65.
    PubMed     Abstract available
    
    
    
73. BERGSTROM G, Rosengren A, Bacsovics Brolin E, Brandberg J, et al
    Body weight at age 20 and in midlife is more important than weight gain for coronary atherosclerosis: Results from SCAPIS.
    Atherosclerosis. 2023;373:46-54.
    PubMed     Abstract available
    
    
    April 2023
74. NAYFEH M, Ahmed AI, Alahdab F, Al Rifai M, et al
    No contrast? No problem! Value in assessing pericoronary fat in non-contrast studies.
    Atherosclerosis. 2023;370:3-4.
    PubMed    
    
    
    
75. TAKAHASHI D, Fujimoto S, Nozaki YO, Kudo A, et al
    Validation and clinical impact of novel pericoronary adipose tissue measurement on ECG-gated non-contrast chest CT.
    Atherosclerosis. 2023;370:18-24.
    PubMed     Abstract available
    
    
    March 2023
76. YANG XH, Zhang BL, Cheng Y, Fu SK, et al
    Association of remnant cholesterol with risk of cardiovascular disease events, stroke, and mortality: A systemic review and meta-analysis.
    Atherosclerosis. 2023;371:21-31.
    PubMed     Abstract available
    
    
    
77. TADA H, Nomura A, Nohara A, Usui S, et al
    Attainment of the low-density lipoprotein cholesterol treatment target and prognosis of heterozygous familial hypercholesterolemia.
    Atherosclerosis. 2023 Mar 17:S0021-9150(23)00103.
    PubMed     Abstract available
    
    
    
78. MOK Y, Wang F, Ballew SH, Menez S, et al
    Kidney function, bone-mineral metabolism markers, and calcification of coronary arteries, aorta, and cardiac valves in older adults.
    Atherosclerosis. 2023;368:35-43.
    PubMed     Abstract available
    
    
    February 2023
79. KATRA P, Hennings V, Nilsson J, Engstrom G, et al
    Plasma levels of CCL21, but not CCL19, independently predict future coronary events in a prospective population-based cohort.
    Atherosclerosis. 2023;366:1-7.
    PubMed     Abstract available
    
    
    
80. DI GIOVANNI G, Kataoka Y, Bubb K, Nelson AJ, et al
    Impact of lipid lowering on coronary atherosclerosis moving from the lumen to the artery wall.
    Atherosclerosis. 2023;367:8-14.
    PubMed     Abstract available
    
    
    
81. FENG X, Zhang C, Huang X, Liu J, et al
    Machine learning improves mortality prediction in three-vessel disease.
    Atherosclerosis. 2023;367:1-7.
    PubMed     Abstract available
    
    
    January 2023
82. MONTONE RA, Rinaldi R, Bonanni A, Severino A, et al
    Impact of air pollution on ischemic heart disease: Evidence, mechanisms, clinical perspectives.
    Atherosclerosis. 2023;366:22-31.
    PubMed     Abstract available
    
    
    
83. TSABAN G, Peles I, Barrett O, Abramowitz Y, et al
    Nonobstructive coronary atherosclerosis is associated with adverse prognosis among patients diagnosed with myocardial infarction without obstructive coronary arteries.
    Atherosclerosis. 2023;366:8-13.
    PubMed     Abstract available
    
    
    
84. DORAJOO R, Ihsan MO, Liu W, Lim HY, et al
    Vascular smooth muscle cells in low SYNTAX scores coronary artery disease exhibit proinflammatory transcripts and proteins correlated with IL1B activation.
    Atherosclerosis. 2023;365:15-24.
    PubMed     Abstract available
    
    
    December 2022
85. TAY KY, Wu KX, Chioh FWJ, Autio MI, et al
    Trans-interaction of risk loci 6p24.1 and 10q11.21 is associated with endothelial damage in coronary artery disease.
    Atherosclerosis. 2022;362:11-22.
    PubMed     Abstract available
    
    
    
86. LIND L, Markstad H, Ahlstrom H, Angeras O, et al
    Obesity is associated with coronary artery stenosis independently of metabolic risk factors: The population-based SCAPIS study.
    Atherosclerosis. 2022;362:1-10.
    PubMed     Abstract available
    
    
    
87. GOWDA SGB, Gowda D, Hou F, Chiba H, et al
    Temporal lipid profiling in the progression from acute to chronic heart failure in mice and ischemic human hearts.
    Atherosclerosis. 2022;363:30-41.
    PubMed     Abstract available
    
    
    
88. MEHTA PK, Huang J, Levit RD, Malas W, et al
    Ischemia and no obstructive coronary arteries (INOCA): A narrative review.
    Atherosclerosis. 2022;363:8-21.
    PubMed     Abstract available
    
    
    
89. JINNOUCHI H, Sakakura K, Taniguchi Y, Tsukui T, et al
    Impact of ultrasound reverberation in calcified coronary arteries: Intravascular ultrasound study.
    Atherosclerosis. 2022;363:1-7.
    PubMed     Abstract available
    
    
    
90. ZIERFUSS B, Hobaus C, Feldscher A, Hannes A, et al
    Lipoprotein (a) and long-term outcome in patients with peripheral artery disease undergoing revascularization.
    Atherosclerosis. 2022;363:94-101.
    PubMed     Abstract available
    
    
    
91. RIKHI R, Hammoud A, Ashburn N, Snavely AC, et al
    Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Atherosclerosis. 2022;363:102-108.
    PubMed     Abstract available
    
    
    November 2022
92. AHN HJ, Lee H, Park HE, Han D, et al
    Changes in metabolic syndrome burden and risk of coronary artery calcification progression in statin-naive young adults.
    Atherosclerosis. 2022;360:27-33.
    PubMed     Abstract available
    
    
    
93. OKADA K, Kikuchi S, Kuji S, Nakayama N, et al
    Impact of early intervention with alogliptin on coronary plaque regression and stabilization in patients with acute coronary syndromes.
    Atherosclerosis. 2022;360:1-7.
    PubMed     Abstract available
    
    
    
94. SEKIMOTO T, Mori H, Koba S, Arai T, et al
    Clinical features and lipid profiles of plaque erosion over lipid-rich plaque versus fibrous plaque in patients with acute coronary syndrome.
    Atherosclerosis. 2022;360:47-52.
    PubMed     Abstract available
    
    
    October 2022
95. YUAN D, Wang P, Jia S, Zhang C, et al
    Lipoprotein(a), high-sensitivity C-reactive protein, and cardiovascular risk in patients undergoing percutaneous coronary intervention.
    Atherosclerosis. 2022 Oct 25. pii: S0021-9150(22)01495.
    PubMed     Abstract available
    
    
    
96. TESCHE C, Bauer MJ, Straube F, Rogowski S, et al
    Association of epicardial adipose tissue with coronary CT angiography plaque parameters on cardiovascular outcome in patients with and without diabetes mellitus.
    Atherosclerosis. 2022 Oct 17. pii: S0021-9150(22)01477.
    PubMed     Abstract available
    
    
    
97. WU S, Yang YM, Zhu J, Xu W, et al
    Impact of glycemic gap on 30-day adverse outcomes in patients with acute ST-segment elevation myocardial infarction.
    Atherosclerosis. 2022;360:34-41.
    PubMed     Abstract available
    
    
    
98. SUN Y, Zhang H, Wang B, Chen C, et al
    Joint exposure to positive affect, life satisfaction, broad depression, and neuroticism and risk of cardiovascular diseases: A prospective cohort study.
    Atherosclerosis. 2022;359:44-51.
    PubMed     Abstract available
    
    
    September 2022
99. DE MARCHIS GM, Dittrich TD, Malik R, Zietz AV, et al
    Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    Atherosclerosis. 2022 Sep 26. pii: S0021-9150(22)01433.
    PubMed     Abstract available
    
    
    
100. NONG JC, You W, Xu T, Meng PN, et al
     Dynamic natural morphologies and component changes in nonculprit subclinical atherosclerosis in patients with acute coronary syndrome at 1-year follow-up and clinical significance at 3-year follow-up.
     Atherosclerosis. 2022;356:1-8.
     PubMed     Abstract available
     
     
     August 2022
101. SCHIANO C, Balbi C, Burrello J, Ruocco A, et al
     De novo DNA methylation induced by circulating extracellular vesicles from acute coronary syndrome patients.
     Atherosclerosis. 2022;354:41-52.
     PubMed     Abstract available
     
     
     
102. CICERO AFG, Salvetti M
     Peripheral artery disease: A highly prevalent untreated and uncontrolled independent cardiovascular disease.
     Atherosclerosis. 2022;354:55-56.
     PubMed    
     
     
     
103. KUMAR R, Bainey KR
     Percutaneous coronary intervention with peripheral artery disease in the contemporary era: Still life or limb?
     Atherosclerosis. 2022;355:45-47.
     PubMed    
     
     
     
104. PINXTERHUIS TH, Ploumen EH, Zocca P, Doggen CJM, et al
     Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials.
     Atherosclerosis. 2022;355:52-59.
     PubMed     Abstract available
     
     
     July 2022
105. KIM C, Choi DW, Lee SJ, Suh Y, et al
     Benefit and risk of prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with chronic kidney disease: A nationwide cohort study.
     Atherosclerosis. 2022;352:69-75.
     PubMed     Abstract available
     
     
     
106. ALFADDAGH A, Kapoor K, Dardari ZA, Bhatt DL, et al
     Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention.
     Atherosclerosis. 2022;353:11-19.
     PubMed     Abstract available
     
     
     
107. AL RIFAI M, Ahmed AI, Al-Mallah MH
     Evaluating coronary atherosclerosis progression among South Asians.
     Atherosclerosis. 2022;353:30-32.
     PubMed    
     
     
     
108. BHATIA HS, Lin F, Thomas IC, Denenberg J, et al
     Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.
     Atherosclerosis. 2022;353:41-46.
     PubMed     Abstract available
     
     
     
109. POST WS, Haberlen SA, Witt MD, Zhang L, et al
     Suboptimal HIV suppression is associated with progression of coronary artery stenosis: The Multicenter AIDS Cohort Study (MACS) longitudinal coronary CT angiography study.
     Atherosclerosis. 2022;353:33-40.
     PubMed     Abstract available
     
     
     June 2022
110. KYTO V, Saraste A, Tornio A
     Early statin use and cardiovascular outcomes after myocardial infarction: A population-based case-control study.
     Atherosclerosis. 2022;354:8-14.
     PubMed     Abstract available
     
     
     
111. CLARKE R, Hammami I, Sherliker P, Valdes-Marquez E, et al
     Oxidized phospholipids on apolipoprotein B-100 versus plasminogen and risk of coronary heart disease in the PROCARDIS study.
     Atherosclerosis. 2022;354:15-22.
     PubMed     Abstract available
     
     
     
112. BOAKYE E, Dardari Z, Obisesan OH, Osei AD, et al
     Sex-and race-specific burden of aortic valve calcification among older adults without overt coronary heart disease: The Atherosclerosis Risk in Communities Study.
     Atherosclerosis. 2022 Jun 13. pii: S0021-9150(22)00290.
     PubMed     Abstract available
     
     
     
113. CALBUREAN PA, Grebenisan P, Nistor IA, Pal K, et al
     Prediction of 3-year all-cause and cardiovascular cause mortality in a prospective percutaneous coronary intervention registry: Machine learning model outperforms conventional clinical risk scores.
     Atherosclerosis. 2022;350:33-40.
     PubMed     Abstract available
     
     
     
114. ROESNER C, Goeller M, Raaz-Schrauder D, Dey D, et al
     Differences of inflammatory cytokine profile in patients with vulnerable plaque: A coronary CTA study.
     Atherosclerosis. 2022;350:25-32.
     PubMed     Abstract available
     
     
     
115. GORDIN D, Bjornstad P, van Raalte DH
     Lipids in CKD: What do we actually know?
     Atherosclerosis. 2022;350:97-99.
     PubMed    
     
     
     
116. SORENSEN IM, Bisgaard LS, Bjergfelt SS, Ballegaard EL, et al
     The metabolic signature of cardiovascular disease and arterial calcification in patients with chronic kidney disease.
     Atherosclerosis. 2022;350:109-118.
     PubMed     Abstract available
     
     
     
117. GROENLAND EH, Heidemann BE, van der Laan SW, van Setten J, et al
     Genetic variants associated with low-density lipoprotein cholesterol and systolic blood pressure and the risk of recurrent cardiovascular disease in patients with established vascular disease.
     Atherosclerosis. 2022;350:102-108.
     PubMed     Abstract available
     
     
     May 2022
118. SCHNITZER F, Forer L, Schonherr S, Gieger C, et al
     Association between a polygenic and family risk score on the prevalence and incidence of myocardial infarction in the KORA-F3 study.
     Atherosclerosis. 2022;352:10-17.
     PubMed     Abstract available
     
     
     
119. WELSH RC, Kay R, Bainey KR
     Evaluation and management of chronic kidney disease patients with stable ischemic heart disease.
     Atherosclerosis. 2022 May 16. pii: S0021-9150(22)00241.
     PubMed    
     
     
     
120. MATSUSHITA K, Gao Y, Sang Y, Ballew SH, et al
     Comparative mortality according to peripheral artery disease and coronary heart disease/stroke in the United States.
     Atherosclerosis. 2022 May 8. pii: S0021-9150(22)00221.
     PubMed     Abstract available
     
     
     
121. WOLTERS FJ, Hilal S, Leening MJG, Kavousi M, et al
     Plasma amyloid-beta40 in relation to subclinical atherosclerosis and cardiovascular disease: A population-based study.
     Atherosclerosis. 2022;348:44-50.
     PubMed     Abstract available
     
     
     
122. DANG AT, Turner AW, Lau P, Mohottalage D, et al
     A novel anti-inflammatory role links the CARS2 locus to protection from coronary artery disease.
     Atherosclerosis. 2022;348:8-15.
     PubMed     Abstract available
     
     
     
123. MATSUOKA S, Kaneko H, Okada A, Itoh H, et al
     Association of retinal atherosclerosis assessed using Keith-Wagener-Barker system with incident heart failure and other atherosclerotic cardiovascular disease: Analysis of 319,501 individuals from the general population.
     Atherosclerosis. 2022;348:68-74.
     PubMed     Abstract available
     
     
     
124. GRUNEIS R, Lamina C, Di Maio S, Schonherr S, et al
     The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
     Atherosclerosis. 2022;349:151-159.
     PubMed     Abstract available
     
     
     
125. LI Q, Chen Y, Yu L, Zhu L, et al
     The relationship between lipoprotein(a) and cardiovascular events in acute coronary syndrome patients with and without chronic kidney disease.
     Atherosclerosis. 2022;349:204-210.
     PubMed     Abstract available
     
     
     
126. LEE H, Park KS, Jeon YJ, Park EJ, et al
     Lipoprotein(a) and subclinical coronary atherosclerosis in asymptomatic individuals.
     Atherosclerosis. 2022;349:190-195.
     PubMed     Abstract available
     
     
     April 2022
127. CHO IY, Yoo JE, Han K, Kim D, et al
     Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction.
     Atherosclerosis. 2022;350:65-72.
     PubMed     Abstract available
     
     
     
128. TENG H, Gao Y, Wu C, Zhang H, et al
     Prevalence and patient characteristics of familial hypercholesterolemia in a Chinese population aged 35-75 years: Results from China PEACE Million Persons Project.
     Atherosclerosis. 2022;350:58-64.
     PubMed     Abstract available
     
     
     
129. NAKAMURA H, Kataoka Y, Nicholls SJ, Puri R, et al
     Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
     Atherosclerosis. 2022 Apr 10. pii: S0021-9150(22)00166.
     PubMed     Abstract available
     
     
     
130. JUKEMA RA, de Winter RW, van Diemen PA, Driessen RS, et al
     The relation of RAAS activity and endothelin-1 levels to coronary atherosclerotic burden and microvascular dysfunction in chest pain patients.
     Atherosclerosis. 2022;347:47-54.
     PubMed     Abstract available
     
     
     
131. AHMED AI, Raggi P, Al-Mallah MH
     Primary vs. secondary prevention and coronary artery calcium: Shades of grey.
     Atherosclerosis. 2022;347:68-69.
     PubMed    
     
     
     
132. DZAYE O, Razavi AC, Michos ED, Mortensen MB, et al
     Coronary artery calcium scores indicating secondary prevention level risk: Findings from the CAC consortium and FOURIER trial.
     Atherosclerosis. 2022;347:70-76.
     PubMed     Abstract available
     
     
     
133. MAURICIO R, Singh K, Sanghavi M, Ayers CR, et al
     Soluble Fms-like tyrosine kinase-1 (sFlt-1) is associated with subclinical and clinical atherosclerotic cardiovascular disease: The Dallas Heart Study.
     Atherosclerosis. 2022;346:46-52.
     PubMed     Abstract available
     
     
     
134. KATSIKI N, Raggi P, Korosoglou G
     Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
     Atherosclerosis. 2022;346:79-81.
     PubMed    
     
     
     
135. YAMAGUCHI M, Hoshino M, Sugiyama T, Kanaji Y, et al
     Association of near-infrared spectroscopy-defined lipid rich plaque with lesion morphology and peri-coronary inflammation on computed tomography angiography.
     Atherosclerosis. 2022;346:109-116.
     PubMed     Abstract available
     
     
     March 2022
136. CHO IY, Chang Y, Sung E, Kim Y, et al
     Fasting ketonuria is inversely associated with coronary artery calcification in non-diabetic individuals.
     Atherosclerosis. 2022;348:1-7.
     PubMed     Abstract available
     
     
     
137. LESZEK A, Poli L, Zbinden S, Godoy LC, et al
     Outcomes with revascularization and medical therapy in patients with coronary disease and chronic kidney disease: A meta-analysis.
     Atherosclerosis. 2022 Mar 4. pii: S0021-9150(22)00106.
     PubMed     Abstract available
     
     
     
138. CHRISTENSEN DM, Strange JE, Phelps M, Schjerning AM, et al
     Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021.
     Atherosclerosis. 2022;346:63-67.
     PubMed     Abstract available
     
     
     
139. BAJAJ R, Eggermont J, Grainger SJ, Raber L, et al
     Machine learning for atherosclerotic tissue component classification in combined near-infrared spectroscopy intravascular ultrasound imaging: Validation against histology.
     Atherosclerosis. 2022;345:15-25.
     PubMed     Abstract available
     
     
     
140. ASZTALOS BF, Hauser TH, Goldfine AB, Welty FK, et al
     The role of HDL- and non-HDL-related parameters in cell-cholesterol efflux capacity.
     Atherosclerosis. 2022;345:1-6.
     PubMed     Abstract available
     
     
     
141. KOBO O, Saada M, Laanmets P, Karageorgiev D, et al
     Impact of peripheral artery disease on prognosis after percutaneous coronary intervention: Outcomes from the multicenter prospective e-ULTIMASTER registry.
     Atherosclerosis. 2022;344:71-77.
     PubMed     Abstract available
     
     
     
142. KOSHY AN, Nerlekar N, Gow PJ, Lim R, et al
     A prospective natural history study of coronary atherosclerosis following liver transplantation.
     Atherosclerosis. 2022;344:40-48.
     PubMed     Abstract available
     
     
     
143. KUNIO M, Gardecki JA, Watanabe K, Nishimiya K, et al
     Histopathological correlation of near infrared autofluorescence in human cadaver coronary arteries.
     Atherosclerosis. 2022;344:31-39.
     PubMed     Abstract available
     
     
     
144. FUJIMOTO D, Otake H, Kawamori H, Toba T, et al
     Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
     Atherosclerosis. 2022;345:44-50.
     PubMed     Abstract available
     
     
     February 2022
145. PASZEK E, Pociask E, Zabczyk M, Piorkowski A, et al
     Active factor XI is associated with the risk of cardiovascular events in stable coronary artery disease patients.
     Atherosclerosis. 2022 Feb 11. pii: S0021-9150(22)00078.
     PubMed     Abstract available
     
     
     
146. STONE PH, Coskun AU
     Coronary angiography-based shear stress computation to identify high-risk coronary artery plaques: Are we there yet?
     Atherosclerosis. 2022;342:25-27.
     PubMed    
     
     
     
147. WENTZEL JJ, Papafaklis MI, Antoniadis AP, Takahashi S, et al
     Sex-related differences in plaque characteristics and endothelial shear stress related plaque-progression in human coronary arteries.
     Atherosclerosis. 2022;342:9-18.
     PubMed     Abstract available
     
     
     
148. HULTEN EA, Gallagher RM
     Coronary revascularization for patients with non-ST elevation myocardial infarction and chronic kidney disease: Better three hours too soon than a minute too late?
     Atherosclerosis. 2022 Feb 1. pii: S0021-9150(22)00042.
     PubMed    
     
     
     January 2022
149. GUDMUNDSSON EF, Bjornsdottir G, Sigurdsson S, Andersen K, et al
     Carotid plaque is strongly associated with coronary artery calcium and predicts incident coronary heart disease in a population-based cohort.
     Atherosclerosis. 2022 Jan 23. pii: S0021-9150(22)00043.
     PubMed     Abstract available
     
     
     
150. YOSHIDA Y, Chen Z, Baudier RL, Krousel-Wood M, et al
     Menopausal hormone therapy and risk of cardiovascular events in women with prediabetes or type 2 diabetes: A pooled analysis of 2917 postmenopausal women.
     Atherosclerosis. 2022;344:13-19.
     PubMed     Abstract available
     
     
     
151. HE X, Dong B, Liang W, Wu Y, et al
     Ischemic risk in patients with heart failure with preserved ejection fraction: A post hoc analysis of the TOPCAT data.
     Atherosclerosis. 2022;344:1-6.
     PubMed     Abstract available
     
     
     
152. ANNEMA W, Gawinecka J, Muendlein A, Saely CH, et al
     Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease.
     Atherosclerosis. 2022;341:27-33.
     PubMed     Abstract available
     
     
     
153. LEE YH, Tsai TH, Chen JH, Huang CJ, et al
     Machine learning of treadmill exercise test to improve selection for testing for coronary artery disease.
     Atherosclerosis. 2022;340:23-27.
     PubMed     Abstract available
     
     
     
154. MA WF, Hodonsky CJ, Turner AW, Wong D, et al
     Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.
     Atherosclerosis. 2022;340:12-22.
     PubMed     Abstract available
     
     
     December 2021
155. ZHANG H, Yi M, Wang Y, Zhang Y, et al
     Air pollution and recurrence of cardiovascular events after ST-segment elevation myocardial infarction.
     Atherosclerosis. 2021;342:1-8.
     PubMed     Abstract available
     
     
     
156. KIM YH, Her AY, Jeong MH, Kim BK, et al
     Outcome of early versus delayed invasive strategy in patients with non-ST-segment elevation myocardial infarction and chronic kidney disease not on dialysis.
     Atherosclerosis. 2021 Dec 1. pii: S0021-9150(21)01463.
     PubMed     Abstract available
     
     
     
157. ZEB I, Jorgensen NW, Blumenthal RS, Burke GL, et al
     Association of inflammatory markers and lipoprotein particle subclasses with progression of coronary artery calcium: The multi-ethnic study of atherosclerosis.
     Atherosclerosis. 2021;339:27-34.
     PubMed     Abstract available
     
     
     
158. DI GIORGI N, Michelucci E, Smit JM, Scholte AJHA, et al
     A specific plasma lipid signature associated with high triglycerides and low HDL cholesterol identifies residual CAD risk in patients with chronic coronary syndrome.
     Atherosclerosis. 2021;339:1-11.
     PubMed     Abstract available
     
     
     
159. DZAYE O, Berning P, Dardari ZA, Berman DS, et al
     Coronary artery calcium is associated with long-term mortality from lung cancer: Results from the Coronary Artery Calcium Consortium.
     Atherosclerosis. 2021;339:48-54.
     PubMed     Abstract available
     
     
     November 2021
160. LOH WJ, Chang X, Aw TC, Phua SK, et al
     Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.
     Atherosclerosis. 2021 Nov 26. pii: S0021-9150(21)01446.
     PubMed     Abstract available
     
     
     
161. CANDREVA A, Pagnoni M, Rizzini ML, Mizukami T, et al
     Risk of myocardial infarction based on endothelial shear stress analysis using coronary angiography.
     Atherosclerosis. 2021 Nov 16. pii: S0021-9150(21)01437.
     PubMed     Abstract available
     
     
     
162. VERDOIA M, De Luca G
     Reply to: "Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead".
     Atherosclerosis. 2021;336:49-50.
     PubMed    
     
     
     
163. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
     Mortality and in-stent thrombosis in COVID-19 patients with STEMI: More work ahead.
     Atherosclerosis. 2021;336:48.
     PubMed    
     
     
     
164. WANG FM, Yang C, Ballew SH, Kalbaugh CA, et al
     Ankle-brachial index and subsequent risk of incident and recurrent cardiovascular events in older adults: The Atherosclerosis Risk in Communities (ARIC) study.
     Atherosclerosis. 2021;336:39-47.
     PubMed     Abstract available
     
     
     October 2021
165. MAHENDIRAN T, Klingenberg R, Nanchen D, Gencer B, et al
     CCN family member 1 (CCN1) is an early marker of infarct size and left ventricular dysfunction in STEMI patients.
     Atherosclerosis. 2021;335:77-83.
     PubMed     Abstract available
     
     
     
166. MARTINEZ-CEBALLOS MA, Sinning Rey JC, Alzate-Granados JP, Mendoza-Pinto C, et al
     Coronary calcium in autoimmune diseases: A systematic literature review and meta-analysis.
     Atherosclerosis. 2021;335:68-76.
     PubMed     Abstract available
     
     
     
167. KIM H, Park JT, Lee J, Jung JY, et al
     The difference between cystatin C- and creatinine-based eGFR is associated with adverse cardiovascular outcome in patients with chronic kidney disease.
     Atherosclerosis. 2021;335:53-61.
     PubMed     Abstract available
     
     
     
168. DOBIASOVA M
     Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors".
     Atherosclerosis. 2021;335:148.
     PubMed    
     
     
     
169. NEGRINI S, von Eckardstein A
     Reply to: "Correspondence to: "Atherogenic index of plasma and the risk of rapid progression of coronary atherosclerosis beyond traditional risk factors"".
     Atherosclerosis. 2021;335:149.
     PubMed    
     
     
     
170. VENKATARAMAN P, Huynh Q, Nicholls SJ, Stanton T, et al
     Impact of a coronary artery calcium-guided statin treatment protocol on cardiovascular risk at 12 months: Results from a pragmatic, randomised controlled trial.
     Atherosclerosis. 2021;334:57-65.
     PubMed     Abstract available
     
     
     
171. HAQUE W, Grandhi GR, Kanaya AM, Kandula NR, et al
     Implications of the 2019 American College of Cardiology/American Heart Association Primary Prevention Guidelines and potential value of the coronary artery calcium score among South Asians in the US: The Mediators of Atherosclerosis in South Asians Li
     Atherosclerosis. 2021;334:48-56.
     PubMed     Abstract available
     
     
     
172. BAMBAGIONI G, Di Mario C, Torguson R, Demola P, et al
     Lipid-rich plaques detected by near-infrared spectroscopy predict coronary events irrespective of age: A Lipid Rich Plaque sub-study.
     Atherosclerosis. 2021;334:17-22.
     PubMed     Abstract available
     
     
     
173. AHMED AI, Han Y, Al Rifai M, Alnabelsi T, et al
     Added prognostic value of plaque burden to computed tomography angiography and myocardial perfusion imaging.
     Atherosclerosis. 2021;334:9-16.
     PubMed     Abstract available
     
     
     September 2021
174. KRISTIANSEN O, Sverre E, Peersen K, Fagerland MW, et al
     The relationship between directly measured statin adherence, self-reported adherence measures and cholesterol levels in patients with coronary heart disease.
     Atherosclerosis. 2021;336:23-29.
     PubMed     Abstract available
     
     
     
175. LIU Y, Liu S, Zhao Z, Song X, et al
     Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
     Atherosclerosis. 2021;333:75-82.
     PubMed     Abstract available
     
     
     
176. AGBAEDENG TA, Noubiap JJ, Mofo Mato EP, Chew DP, et al
     Polygenic risk score and coronary artery disease: A meta-analysis of 979,286 participant data.
     Atherosclerosis. 2021;333:48-55.
     PubMed     Abstract available
     
     
     
177. ALI HJ, Al-Mallah MH
     Time for sex specific atherosclerosis risk prediction.
     Atherosclerosis. 2021;333:87-88.
     PubMed    
     
     
     
178. PEPE M, Napoli G, Carulli E, Moscarelli M, et al
     Autoimmune diseases in patients undergoing percutaneous coronary intervention: A risk factor for in-stent restenosis?
     Atherosclerosis. 2021;333:24-31.
     PubMed     Abstract available
     
     
     
179. USUI E, Matsumura M, Mintz GS, Zhou Z, et al
     Clinical outcomes of low-intensity area without attenuation and cholesterol crystals in non-culprit lesions assessed by optical coherence tomography.
     Atherosclerosis. 2021;332:41-47.
     PubMed     Abstract available
     
     
     
180. VERNON ST, Kott KA, Hansen T, Zhang KJ, et al
     Coronary artery disease burden in women poorly explained by traditional risk factors: Sex disaggregated analyses from the BioHEART-CT study.
     Atherosclerosis. 2021;333:100-107.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge.